Developing a Successful Biopharmaceutical Pricing & Market Access Strategy, register now

Registration is now open for the 2026 “Developing a Successful Biopharmaceutical Pricing & Market Access Strategy” executive education programme, a collaboration between Windrose Consulting Group and the University of Cambridge MPhil in Bioscience Enterprise (MBE).

This virtual course will run across seven sessions, held on Fridays from 24 April to 5 June 2026, 1:00–3:00pm BST, online.

The programme combines expert led lectures, case studies, and practical exercises. It is designed to be highly interactive, with an emphasis on group discussion and real world application. Our aim is not only to provide the underlying theory, but to help participants understand how to apply these concepts within their current role or future career.

The course is delivered by industry leaders, including Matt Storer, Zameer Merchant, Anaïs Frappé, Gordon Bache, Andrew Walker, Professor Seamus Higson, Dr David Hampton, and Lisa (Elizabeth) Hall CBE.

All course information can be found on our P&MA course page, which can be found by clicking below:

Previous
Previous

The Emergence of Cancer Vaccines: Reframing Value Demonstration, Pricing, and Access

Next
Next

Timothy Rhee joins Windrose US